- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- June 2025
- 150 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- April 2025
- 183 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- March 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- August 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- July 2024
- 150 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- July 2024
- 100 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- May 2023
- 121 Pages
Global
From €3500EUR$4,281USD£3,144GBP
Systane is a brand of eye drops used to treat dry eye syndrome, a common optical disorder. It is a lubricant eye drop that helps to reduce the symptoms of dry eye, such as burning, stinging, and irritation. Systane is available in both preservative-free and preservative-containing formulations. It is also available in a variety of forms, including drops, gels, and ointments. Systane is used to treat both short-term and long-term dry eye symptoms.
Systane is a popular brand of eye drops in the optical disorder drugs market. It is widely available in pharmacies and online retailers. Systane is often recommended by eye care professionals as a first-line treatment for dry eye syndrome.
Some companies in the Systane market include Alcon, Bausch + Lomb, Allergan, and Novartis. Show Less Read more